TY - JOUR
T1 - Differential retinoblastoma and p16(INK4A) protein expression in neuroendocrine tumors of the lung
AU - Dosaka-Akita, Hirotoshi
AU - Cagle, Philip T.
AU - Hiroumi, Hiromitsu
AU - Fujita, Masahiro
AU - Yamashita, Motoyuki
AU - Sharma, Anupama
AU - Kawakami, Yoshikazu
AU - Benedict, William F.
PY - 2000/2/1
Y1 - 2000/2/1
N2 - BACKGROUND. Neuroendocrine neoplasms of the lung represent a wide spectrum of phenotypically and biologically distinct entities. Their histopathologic, diagnosis, which carries therapeutic and prognostic significance, may sometimes be difficult because of their overlapping features. We previously demonstrated that large cell neuroendocrine carcinomas (LCNECs) and small cell lung carcinomas (SCLCs) failed to show positive nuclear staining of RB protein (RB-), whereas typical and atypical carcinoids (TCs and ACs) showed nuclear RB immunostaining [RB+). METHODS. In the current study, a series of 58 surgically resected lung tumors, of which 33 tumors were initially diagnosed as SCLCs and 25 as TCs or ACs, were studied for RB and p16 protein expression by immunohistochemistry. They were also reviewed for their pathologic diagnosis; the reviewers were blinded to the RB and p16 protein status. RESULTS. Nineteen tumors were diagnosed as TCs, 5 as ACs, 7 as LCNECs, and 27 as SCLCs. Three of seven LCNECs were RB+, whereas the other four were RB-. In contrast, all 19 TCs were RB+ and all 27 SCLCs were RB-. In addition, two of five ACs were RB+, whereas the other three were RB-. Interestingly, all 3 RB+ LCNECs and the 1 RB+ AC tested failed to show nuclear staining of p16 protein in any tumor cells (p 16-), although some normal stromal cells showed nuclear staining of p 16 protein (p 16 +) as positive internal controls, indicating loss of p 16 function in these tumors. It is also noteworthy that the three RB+ LCNECs were initially diagnosed as SCLCs and one of the RB- ACs was initially considered a TC with the exception of TCs, tumors were significantly more prevalent among heavy smokers with >20 pack-years compared with nonsmokers and light smokers with ≤20 pack-years (P < 0.01). CONCLUSIONS. These findings suggest that all SCLCs and LCNECs have abnormalities in the p16:RB pathway, as do at least certain ACs, whereas the p16:RB pathway is normal in TCs.
AB - BACKGROUND. Neuroendocrine neoplasms of the lung represent a wide spectrum of phenotypically and biologically distinct entities. Their histopathologic, diagnosis, which carries therapeutic and prognostic significance, may sometimes be difficult because of their overlapping features. We previously demonstrated that large cell neuroendocrine carcinomas (LCNECs) and small cell lung carcinomas (SCLCs) failed to show positive nuclear staining of RB protein (RB-), whereas typical and atypical carcinoids (TCs and ACs) showed nuclear RB immunostaining [RB+). METHODS. In the current study, a series of 58 surgically resected lung tumors, of which 33 tumors were initially diagnosed as SCLCs and 25 as TCs or ACs, were studied for RB and p16 protein expression by immunohistochemistry. They were also reviewed for their pathologic diagnosis; the reviewers were blinded to the RB and p16 protein status. RESULTS. Nineteen tumors were diagnosed as TCs, 5 as ACs, 7 as LCNECs, and 27 as SCLCs. Three of seven LCNECs were RB+, whereas the other four were RB-. In contrast, all 19 TCs were RB+ and all 27 SCLCs were RB-. In addition, two of five ACs were RB+, whereas the other three were RB-. Interestingly, all 3 RB+ LCNECs and the 1 RB+ AC tested failed to show nuclear staining of p16 protein in any tumor cells (p 16-), although some normal stromal cells showed nuclear staining of p 16 protein (p 16 +) as positive internal controls, indicating loss of p 16 function in these tumors. It is also noteworthy that the three RB+ LCNECs were initially diagnosed as SCLCs and one of the RB- ACs was initially considered a TC with the exception of TCs, tumors were significantly more prevalent among heavy smokers with >20 pack-years compared with nonsmokers and light smokers with ≤20 pack-years (P < 0.01). CONCLUSIONS. These findings suggest that all SCLCs and LCNECs have abnormalities in the p16:RB pathway, as do at least certain ACs, whereas the p16:RB pathway is normal in TCs.
KW - Diagnostic marker
KW - Immunohistochemistry
KW - Neuroendocrine tumors of the lung
KW - P16(INK4A) protein
KW - Retinoblastoma protein
UR - http://www.scopus.com/inward/record.url?scp=0034142330&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=0034142330&partnerID=8YFLogxK
U2 - 10.1002/(SICI)1097-0142(20000201)88:3<550::AID-CNCR9>3.0.CO;2-D
DO - 10.1002/(SICI)1097-0142(20000201)88:3<550::AID-CNCR9>3.0.CO;2-D
M3 - Article
C2 - 10649246
AN - SCOPUS:0034142330
VL - 88
SP - 550
EP - 556
JO - Cancer
JF - Cancer
SN - 0008-543X
IS - 3
ER -